| JXSL2000124 | Amivantamab 注射液 | amivantamab | Injection | Biological Products | Import Drug Application | 2020-07-09 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-07-08 | view |
| JXHB2100019 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-02-05 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Excella GmbH;Actelion Pharmaceuticals Ltd | In Review | 2021-02-05 | view |
| JXHL2000083 | Pimodivir速释薄膜包衣片 | pimodivir | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-04-20 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-04-18 | view |
| JXHL2000213 | JNJ-53718678口服混悬液 | rilematovir | Suspension | Chemical Drugs(1) | Import Drug Application | 2020-07-17 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-07-16 | view |
| JXHL2000297 | JNJ-53718678口服混悬液 | rilematovir | Suspension | Chemical Drugs(1) | Import Drug Application | 2020-11-09 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-11-07 | view |
| JXHL2000210 | Lazertinib 片 | lazertinib mesylate | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-07-10 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-07-09 | view |
| JXSB2100021 | Amivantamab 注射液 | amivantamab | Injection | Biological Products(1) | Supplementary Application | 2021-03-11 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Cilag AG;Janssen Research & Development LLC | In Review | 2022-01-27 | view |
| JXSL2000123 | Amivantamab 注射液 | amivantamab | Injection | Biological Products | Import Drug Application | 2020-07-09 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-07-08 | view |
| JXHL2000208 | Lazertinib 片 | lazertinib mesylate | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-07-10 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-07-09 | view |
| JXHB2100027 | Lazertinib 片 | lazertinib mesylate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-03-11 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC;Patheon Pharmaceuticals Inc | In Review | 2022-01-27 | view |
| JXSL2000122 | Amivantamab 注射液 | amivantamab | Injection | Biological Products | Import Drug Application | 2020-07-09 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-07-08 | view |
| JXHL2000236 | JNJ-53718678口服混悬液 | rilematovir | Suspension | Chemical Drugs(1) | Import Drug Application | 2020-08-24 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Sciences Ireland Uc | In Review | 2020-08-21 | view |
| JXHL2000207 | Lazertinib 片 | lazertinib mesylate | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-07-10 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-07-09 | view |
| JXHB2100020 | 司来帕格片 | selexipag | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-02-05 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Excella GmbH;Actelion Pharmaceuticals Ltd | In Review | 2021-02-05 | view |
| JXHL2000150 | JNJ-73763989注射剂 | JNJ-73763989 | Injection | Chemical Drugs(1) | Import Drug Application | 2020-06-28 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-06-25 | view |
| JXSL2000142 | Amivantamab 注射液 | amivantamab | Injection | Biological Products(1) | Import Drug Application | 2020-08-06 | 强生（中国）投资有限公司 | Johnson & Johnson (CHINA) Investment Ltd;Janssen Research & Development LLC | In Review | 2020-08-05 | view |
